[Evaluation of reimbursement applications for new drugs].

Abstract

BACKGROUND It has been suggested that decisions about which drugs should be reimbursed by the Norwegian National Insurance Administration (NIA) are ad hoc and made without explicit criteria for evaluating applications. MATERIAL AND METHODS We assessed all documents that we were able to retrieve from the NIA for a sample of 31 applications to add new drugs… (More)

Topics

  • Presentations referencing similar topics